Fused Pyrimidine-Based Drug Discovery (Paperback)

Fused Pyrimidine-Based Drug Discovery covers all categories of fused-pyrimidines along with pharmacological and in silico studies. It covers the chemistry and biological activities, as well as the design of novel fused-pyrimidine scaffolds. N-Heterocyclic scaffolds are found in most known drug candidates, and are of interest to medicinal and organic chemists to design, synthesize and evaluate their biological properties. A variety of fused-pyrimidine molecules have been synthesized and extracted from natural resources, and are found to exhibit various biological activities such as antifolates, anticancer agents, analgesics, antimetabolites, CNS active agents and many more. Some of these scaffolds like purines are also known to have involvement in biological processes and are part of the framework of genetic material. This book focuses on the classification, structural chemistry, and chemical and physical properties along with various approaches for their synthesis. This book is ideal for researchers in organic chemistry both in academic and industrial settings, postgraduates in chemistry and medicinal chemistry.

General

Imprint:	Elsevier - Health Sciences Division
Country of origin:	United States
Series:	Heterocyclic Drug Discovery
Release date:	October 2022
First published:	2023
Editors:	Raj Kumar
Dimensions:	229 x 152mm (L x W)
Format:	Paperback
Pages:	378
ISBN-13:	978-0-443-18616-5
Categories:	Books > Science & Mathematics > Chemistry > Organic chemistry > General
LSN:	0-443-18616-2
Barcode:	9780443186165

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!